BioCentury
ARTICLE | Company News

Galen, Provalis deal

February 6, 2006 8:00 AM UTC

PRO sold its Provalis Healthcare pharmaceuticals division to GAL's Kogen Ltd. subsidiary for £10.5 million ($18.6 million) in cash. PRO said the sale will let it focus on its Medical Diagnostics divis...